Panagora Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-16
Closed 2772
2020
Q2
$0 Sell
16
-193
-92% -$2.3K ﹤0.01% 2666
2020
Q1
$2K Sell
209
-6,369
-97% -$89K ﹤0.01% 2401
2019
Q4
$150K Sell
6,578
-91
-1% -$1.3K ﹤0.01% 1700
2019
Q3
$95K Sell
6,669
-14,804
-69% -$217K ﹤0.01% 1841
2019
Q2
$286K Sell
21,473
-53,091
-71% -$802K ﹤0.01% 1653
2019
Q1
$1.29M Sell
74,564
-3,805
-5% -$56.7K 0.01% 1023
2018
Q4
$1.07M Buy
78,369
+14,229
+22% +$251K 0.01% 1046
2018
Q3
$1.38M Buy
64,140
+22,624
+54% +$688K 0.01% 988
2018
Q2
$1.78M Buy
41,516
+22,349
+117% +$1.02M 0.01% 925
2018
Q1
$1.25M Buy
19,167
+1,848
+11% +$131K ﹤0.01% 1076
2017
Q4
$1.26M Buy
17,319
+17,133
+9,211% +$1.42M ﹤0.01% 1048
2017
Q3
$17K Hold
186
﹤0.01% 2194
2017
Q2
$12K Hold
186
﹤0.01% 2356
2017
Q1
$40K Sell
186
-3,841
-95% -$549K ﹤0.01% 2053
2016
Q4
$373K Sell
4,027
-9,184
-70% -$1.03M ﹤0.01% 1546
2016
Q3
$1.79M Buy
13,211
+13,025
+7,003% +$1.29M 0.01% 962
2016
Q2
$19K Sell
186
-363
-66% -$45K ﹤0.01% 2169
2016
Q1
$90K Buy
549
+363
+195% +$73.6K ﹤0.01% 1884
2015
Q4
$61K Hold
186
﹤0.01% 1928
2015
Q3
$60K Sell
186
-385
-67% -$169K ﹤0.01% 1949
2015
Q2
$228K Buy
571
+2
+0.4% +$850 ﹤0.01% 1620
2015
Q1
$280K Buy
+569
New +$220K ﹤0.01% 1540

Other funds holding LUMO

Panagora Asset Management's LUMO Position: Q3 2020 in Review

Panagora Asset Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2020, closing a stake of 16 shares.

Panagora Asset Management first reported a position in LUMO in Q1 2015 and held it in 22 quarters. The position peaked at $1.79M in Q3 2016. 38 funds tracked by Wall St. Rank hold LUMO as of Q3 2020.

  • Panagora Asset Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Panagora Asset Management sold 16 Lumos Pharma, Inc. Common Stock shares in Q3 2020.
  • Panagora Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2015 and held it in 22 quarters.
  • Panagora Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $1.79M in Q3 2016.
  • 38 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2020.

Based on Panagora Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.